Zinc for Neurotransmitter Imbalance

References

1. [1] Yuping Li et al.. Ann Med. 2026. The role of zinc homeostasis in major depressive disorder: heterogeneous pathological mechanisms and therapeutic implications. doi:10.1080/07853890.2025.2611191 PubMed
2. [2] Arik Monash et al.. J Neurochem. 2025. Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review. doi:10.1111/jnc.70187 PubMed
3. [3] Maria Francesca Astorino et al.. Am J Med Genet B Neuropsychiatr Genet. 2025. The Multifaceted Etiology of Mental Disorders With a Focus on Trace Elements, a Review of Recent Literature. doi:10.1002/ajmg.b.33045 PubMed
4. [4] Anna Lis et al.. Medicina (Kaunas). 2025. The Role of Various Types of Diets in the Treatments of Depressive Disorders. doi:10.3390/medicina61101737 PubMed
5. [5] Mihai Nechifor. Biomedicines. 2025. Magnesium and Zinc in Schizophrenia. doi:10.3390/biomedicines13092249 PubMed
6. [6] Yijuan Xiang et al.. Nat Commun. 2025. Synaptotagmin-1 serves as a primary Zn2+ sensor to mediate spontaneous neurotransmitter release under pathological conditions. doi:10.1038/s41467-025-62496-1 PubMed
7. [7] Anita Horvatić et al.. Metabolites. 2025. Combining Metabolomics and Proteomics to Reveal Key Serum Compounds Related to Canine Intervertebral Disc Herniation. doi:10.3390/metabo15060396 PubMed
8. [8] Zuzanna Majewska et al.. Int J Mol Sci. 2025. Mineral Homeostasis and Depression: Implications for Prevention and Therapeutic Support-A Narrative Review. doi:10.3390/ijms26146637 PubMed
9. [9] Arthur N Khaziev et al.. Biometals. 2025. Exogenous nanomolar zinc ion (Zn2+) as a negative modulator of neuromuscular transmission via presynaptic mechanism in mouse diaphragm. doi:10.1007/s10534-025-00740-3 PubMed
10. [10] Dushyant Kumar Srivastava et al.. Nature. 2024. Structure of the human dopamine transporter and mechanisms of inhibition. doi:10.1038/s41586-024-07739-9 PubMed
11. [11] Michael Aschner et al.. Chem Biol Interact. 2024. Molecular mechanisms of zinc oxide nanoparticles neurotoxicity. doi:10.1016/j.cbi.2024.111245 PubMed
12. [12] Zi-Wei Chen et al.. J Biol Chem. 2024. Three classes of propofol binding sites on GABAA receptors. doi:10.1016/j.jbc.2024.107778 PubMed
13. [13] Ziyan Zhong et al.. Drug Des Devel Ther. 2024. Jujuboside A Regulates Calcium Homeostasis and Structural Plasticity to Alleviate Depression-Like Behavior via Shh Signaling in Immature Neurons. doi:10.2147/DDDT.S479055 PubMed
14. [14] Adriana Fontes et al.. Int J Mol Sci. 2024. Metabolic Derangement of Essential Transition Metals and Potential Antioxidant Therapies. doi:10.3390/ijms25147880 PubMed
15. [15] Martina Baliova et al.. Exp Parasitol. 2024. Manganese- and zinc-coordinated interaction of Schistosoma japonicum glutathione S-transferase with neurotransmitter transporters GlyT1 and GAT3 in vitro. doi:10.1016/j.exppara.2024.108721 PubMed
16. [16] Oluwafunmbi Ebenezer Ogunmiluyi et al.. J Toxicol. 2024. Zinc or/and Vitamin E Supplementation Mitigates Oxidative Stress, Neuroinflammation, Neurochemical Changes and Behavioural Deficits in Male Wistar Rats Exposed to … doi:10.1155/jt/9317271 PubMed
17. [17] Jacek Baj et al.. Int J Mol Sci. 2023. Consequences of Disturbing Manganese Homeostasis. doi:10.3390/ijms241914959 PubMed
18. [18] Madelyn A Arruebarrena et al.. Int J Mol Sci. 2023. Mechanisms of Cadmium Neurotoxicity. doi:10.3390/ijms242316558 PubMed
19. [19] Kurt A Jellinger. J Neural Transm (Vienna). 2023. Depression in dementia with Lewy bodies: a critical update. doi:10.1007/s00702-023-02669-8 PubMed
20. [20] Clavia Ruth Wooton-Kee. Pharmacol Ther. 2023. Therapeutic implications of impaired nuclear receptor function and dysregulated metabolism in Wilson's disease. doi:10.1016/j.pharmthera.2023.108529 PubMed
21. [21] Agnieszka Jankowska-Kulawy et al.. Int J Mol Sci. 2022. Metabolic and Cellular Compartments of Acetyl-CoA in the Healthy and Diseased Brain. doi:10.3390/ijms231710073 PubMed
22. [22] Chao Tan et al.. Neuron. 2022. Rebuilding essential active zone functions within a synapse. doi:10.1016/j.neuron.2022.01.026 PubMed
23. [23] Chen Zhang et al.. Open Biol. 2022. Neuronal signalling of zinc: from detection and modulation to function. doi:10.1098/rsob.220188 PubMed
24. [24] Fan Yu et al.. Sci Total Environ. 2022. Zinc alters behavioral phenotypes, neurotransmitter signatures, and immune homeostasis in male zebrafish (Danio rerio). doi:10.1016/j.scitotenv.2022.154099 PubMed
25. [25] Rebecca F Krall et al.. Neuroscience. 2021. The Function and Regulation of Zinc in the Brain. doi:10.1016/j.neuroscience.2021.01.010 PubMed
26. [26] Roser Granero et al.. Nutrients. 2021. The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized … doi:10.3390/nu13114059 PubMed
27. [27] Elzbieta Zieminska et al.. Front Mol Neurosci. 2021. Zinc and Copper Brain Levels and Expression of Neurotransmitter Receptors in Two Rat ASD Models. doi:10.3389/fnmol.2021.656740 PubMed
28. [28] Pan Chen et al.. Sleep. 2021. A potential role for zinc in restless legs syndrome. doi:10.1093/sleep/zsaa236 PubMed
29. [29] N Berríos-Cartagena et al.. Neurochem Res. 2021. Effects of Zinc, Mercury, or Lead on [3H]MK-801 and [3H]Fluorowillardiine Binding to Rat Synaptic Membranes. doi:10.1007/s11064-021-03407-w PubMed
30. [30] Anatoly V Skalny et al.. Adv Food Nutr Res. 2021. Zinc. doi:10.1016/bs.afnr.2021.01.003 PubMed
31. [31] Lin Ren et al.. Angew Chem Int Ed Engl. 2020. Amperometric Measurements and Dynamic Models Reveal a Mechanism for How Zinc Alters Neurotransmitter Release. doi:10.1002/anie.201913184 PubMed
32. [32] Zin W Myint et al.. Ann Hematol. 2018. Copper deficiency anemia: review article. doi:10.1007/s00277-018-3407-5 PubMed
33. [33] Rosa María Martínez García et al.. Nutr Hosp. 2018. [Nutrition strategies that improve cognitive function]. doi:10.20960/nh.2281 PubMed
34. [34] Brendan B McAllister et al.. Neurosci Biobehav Rev. 2017. Zinc transporter 3 (ZnT3) and vesicular zinc in central nervous system function. doi:10.1016/j.neubiorev.2017.06.006 PubMed
35. [35] Yuho Okita et al.. Front Neurosci. 2017. Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies. doi:10.3389/fnins.2017.00114 PubMed
36. [36] Jack Tuszynski et al.. Curr Pharm Des. 2017. Ion Channel and Neurotransmitter Modulators as Electroceutical Approaches to the Control of Cancer. doi:10.2174/1381612823666170530105837 PubMed
37. [37] Chelsea A Barr et al.. Essays Biochem. 2017. The zinc paradigm for metalloneurochemistry. doi:10.1042/EBC20160073 PubMed
38. [38] Célia S Bonnet et al.. Chimia (Aarau). 2016. Smart Contrast Agents for Magnetic Resonance Imaging. doi:10.2533/chimia.2016.102 PubMed
39. [39] Yoan Cherasse et al.. Mol Nutr Food Res. 2015. Zinc-containing yeast extract promotes nonrapid eye movement sleep in mice. doi:10.1002/mnfr.201500082 PubMed
40. [40] V Cappelli et al.. Minerva Ginecol. 2015. [Evaluation of the efficacy of a new nutraceutical product in the treatment of postmenopausal symptoms]. PubMed
41. [41] Carla Marchetti. Biometals. 2014. Interaction of metal ions with neurotransmitter receptors and potential role in neurodiseases. doi:10.1007/s10534-014-9791-y PubMed
42. [42] Bo Wang et al.. Oxid Med Cell Longev. 2013. Cadmium and its neurotoxic effects. doi:10.1155/2013/898034 PubMed
43. [43] Anthony Lau et al.. Pflugers Arch. 2010. Glutamate receptors, neurotoxicity and neurodegeneration. doi:10.1007/s00424-010-0809-1 PubMed
44. [44] Elise C Cope et al.. Curr Opin Clin Nutr Metab Care. 2010. Role of zinc in the development and treatment of mood disorders. doi:10.1097/MCO.0b013e32833df61a PubMed
45. [45] Freimut Schliess et al.. Metab Brain Dis. 2009. RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia. doi:10.1007/s11011-008-9125-2 PubMed
46. [46] M B H Youdim. Neurotox Res. 2008. Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus. doi:10.1007/BF03033574 PubMed
47. [47] Robert O Wright et al.. J Nutr. 2007. Metals and neurotoxicology. doi:10.1093/jn/137.12.2809 PubMed
48. [48] K Nørgaard-Nielsen et al.. Handb Exp Pharmacol. 2006. Zn2+ modulation of neurotransmitter transporters. doi:10.1007/3-540-29784-7_1 PubMed
49. [49] Atsushi Takeda et al.. J Neurosci Res. 2004. Differential effects of zinc on glutamatergic and GABAergic neurotransmitter systems in the hippocampus. doi:10.1002/jnr.10846 PubMed
50. [50] Atsushi Takeda. Yakugaku Zasshi. 2004. [Essential trace metals and brain function]. doi:10.1248/yakushi.124.577 PubMed
51. [51] D E Barañano et al.. Trends Neurosci. 2001. Atypical neural messengers. doi:10.1016/s0166-2236(00)01716-1 PubMed
52. [52] P Q Trombley et al.. Biochemistry (Mosc). 2000. Interactions between carnosine and zinc and copper: implications for neuromodulation and neuroprotection. PubMed
53. [53] O Rossetto et al.. Clin Chim Acta. 2000. Bacterial toxins with intracellular protease activity. doi:10.1016/s0009-8981(99)00228-4 PubMed
54. [54] J C Wallwork. Prog Food Nutr Sci. 1987. Zinc and the central nervous system. PubMed